Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Orladeyo (berotralstat)
.
Show all posts
Showing posts with label
Orladeyo (berotralstat)
.
Show all posts
Saturday, February 6, 2021
FDA Approves Orladeyo (berotralstat) as the First Oral, Once-Daily Therapy to Prevent Attacks in Hereditary Angioedema Patients
›
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) announced the U.S. Food and Drug Administration (FDA) approval of oral, once-daily Orladeyo ...
›
Home
View web version
